The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

In a report released on March 6, Shane Storey from Wilsons maintained a Buy rating on Clarity Pharmaceuticals Ltd. (CU6 – Research Report), ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OrthoPediatrics (KIDS – Research Report) and ...

HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to ...

HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

Despite challenges, Mayne Pharma Group Ltd (MAYNF) reports a 13% revenue increase and significant profitability improvements, driven by robust performance in the women's health segment.

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next. Announced on Friday after months of speculation, US pharma giant Cosette launched its $ ...